Newsroom Bayer
Bayer submits application to U.S. FDA for third indication of darolutamide Not intended for U.S. and UK Media Submission is based on positive results from the pivotal Phase III ARANOTE trial which showed that darolutamide plus androgen deprivation therapy (ADT) significantly reduced the risk of radiological progression or death by 46% compared ...
After cutting 1,500 in Q1, Bayer laid off 1,700 more in Q2 - Fierce …
Aug 6, 2024 · Bayer’s transformation under CEO Bill Anderson has picked up momentum. In reporting second-quarter earnings on Tuesday, the company revealed it has cut 3,200 jobs since the start of this year.
Bayer CEO calls German group ‘badly broken’ as he holds off split
Mar 5, 2024 · Struggling German conglomerate Bayer is “badly broken” and currently unable to split up, chief executive Bill Anderson said on Tuesday.
Bayer must pay $78 million in latest Roundup cancer trial, jury finds
Oct 10, 2024 · By Brendan Pierson (Reuters) -Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday.
Bayer calls off break-up to tackle challenges for up to 3 years
Mar 5, 2024 · Bayer won a case last week but its track record in court has been spotty. The company settled cases for up to $9.6 billion in 2020 but failed to win approval for a proposal to handle future...
Bayer aims to enhance performance and regain strategic flexibility …
Mar 5, 2024 · Bayer will also address its debt. The company aims to advance toward an A rating through profitable growth as well as a planned amendment to its dividend policy. Bayer has proposed to pay out the legally required minimum for three years, as previously announced.
Bayer U.S. News & Stories | Bayer United States
As a leader in health and nutrition, something is always happening at Bayer and in the countless communities we serve. Take a look below—and check back often—to explore some of our most exciting stories as they emerge.
Bayer Slumps Most Ever After Roundup Verdict, Drug Setback
Nov 20, 2023 · Bayer AG dropped the most in its history, losing about €7.6 billion ($8.3 billion) in market value, after suffering major courtroom and drug-development setbacks that raise pressure on its new ...
Bayer wins victory in US legal battle against Roundup cancer claims
Aug 16, 2024 · Bayer won a legal victory in its fight to limit liability from claims that its Roundup weed killer causes cancer, as a U.S. appeals court on Thursday said federal law shields the German company...
Bayer Aktiengesellschaft (BAYRY) Latest Stock News & Headlines - Yahoo ...
Get the latest Bayer Aktiengesellschaft (BAYRY) stock news and headlines to help you in your trading and investing decisions.